Announcement

Collapse
No announcement yet.

Pharmacol Res. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Pharmacol Res. Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19


    Pharmacol Res. 2020 Apr 10:104808. doi: 10.1016/j.phrs.2020.104808. [Epub ahead of print]
    Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).


    Abedi F1, Rezaee R2, Karimi G3.

    Author information




    PMID:32283223DOI:10.1016/j.phrs.2020.104808

Working...
X